Ceftazidime Dosing for Hemodialysis Patients
For patients on hemodialysis three times per week, administer ceftazidime 1 g IV immediately after each dialysis session. This post-dialysis dosing strategy ensures adequate drug exposure while accounting for the significant removal of ceftazidime during dialysis (approximately 50-55% of the dose is cleared during a 4-hour session) 1, 2, 3.
Standard Dosing Regimen
- Give 1 g IV ceftazidime after each hemodialysis session (three times weekly) 1, 4, 2
- Administer a loading dose of 1 g before initiating maintenance dosing to achieve therapeutic levels more rapidly 2, 3
- Always dose post-dialysis, never pre-dialysis, to prevent premature drug removal and ensure reliable pharmacodynamic target attainment 1, 4
Pharmacokinetic Rationale
Ceftazidime is eliminated almost exclusively by glomerular filtration (80-90% excreted unchanged in urine), making dosing adjustments essential in renal failure 2. The elimination half-life extends from approximately 1.9 hours in normal renal function to 33.6 hours in anuric patients between dialysis sessions 3. During a 4-hour hemodialysis session, the half-life decreases dramatically to 3.3 hours, with dialyzer clearance of approximately 55.6 mL/min 3.
Pharmacodynamic Target Attainment
The 1 g post-dialysis regimen reliably achieves the critical pharmacodynamic target of maintaining drug concentrations above the minimum inhibitory concentration (MIC) for >70% of the interdialytic interval (%T>MIC) 5, 6. Specifically:
- For 48-hour interdialytic intervals: 1 g post-dialysis achieves >90% probability of target attainment for organisms with MICs ≤8 μg/mL 6
- For 72-hour interdialytic intervals: 1 g post-dialysis is adequate for organisms with MICs ≤4 μg/mL; consider 2 g for organisms with MICs up to 8 μg/mL 6
- Peak concentrations after 1 g dosing reach approximately 78 mg/L, with 48-hour and 72-hour trough levels of 37 mg/L and 13 mg/L, respectively 5
Alternative Dosing Considerations
For more resistant organisms (MIC 16-32 μg/mL) or critically ill patients, consider daily dosing of 500 mg to 1 g regardless of dialysis schedule, as this may provide superior target attainment 6. However, this approach requires more frequent administration and may not be practical in outpatient dialysis settings 1.
The 2 g post-dialysis dose is equally effective and well-tolerated but may not be necessary for most infections, as 1 g achieves 100% T>MIC for susceptible pathogens 5. Reserve the higher dose for:
- Severe infections with high bacterial burden 2
- Organisms with MICs of 8 μg/mL during 72-hour interdialytic intervals 6
- Immunocompromised patients 2
Critical Pitfalls to Avoid
Do not reduce the individual dose size—instead, extend the dosing interval to preserve ceftazidime's concentration-dependent bactericidal activity 4. Smaller doses compromise efficacy even when given more frequently 1.
Do not administer ceftazidime before dialysis, as this results in significant drug loss (>50% removal during dialysis) and subtherapeutic plasma concentrations 4, 3, 7.
Monitor for neurotoxicity, particularly in patients with residual renal dysfunction or those receiving higher doses, as ceftazidime has moderate pro-convulsive activity (approximately 17% of penicillin G) 4.
Special Clinical Scenarios
For catheter-related bloodstream infections in hemodialysis patients, combine systemic therapy (1 g IV post-dialysis) with antibiotic lock therapy using ceftazidime 0.5 mg/mL plus heparin 100 IU/mL 1.
No hepatic dose adjustment is required, as ceftazidime elimination is not affected by liver dysfunction 2.
For patients on continuous venovenous hemodialysis (CVVHD), use 2.5 g every 12 hours as 2-hour infusions rather than the intermittent hemodialysis regimen 7.